Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole

NCT02806050 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02806050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02806050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Completed
Start date
September 16, 2016
Completion date
September 28, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer